Protagenic Therapeutics, Inc.\new (PTIX) Return on Capital Employed [ROCE] (2016 - 2026)
Protagenic Therapeutics, Inc.\new's Return on Capital Employed [ROCE] came in at -145.10% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 33.19 percentage points from the prior quarter.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.\new's Return on Capital Employed [ROCE] was -537.27%.
- Return on Capital Employed [ROCE] carries a five-year change of -457.19 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Capital Employed [ROCE] was -259.50% in FY2024 (-177.57 pp), -81.93% in FY2023 (-39.72 pp) and -42.21% in FY2022 (+37.87 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.86% |
| 10 | Protagenic Therapeutics, Inc.\new | 1.30 Mn | 1.30 Mn | - | -145.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -145.10% |
| Mar 31, 2026 | -111.91% |
| Dec 31, 2024 | -527.32% |
| Sep 30, 2024 | -712.12% |
| Jun 30, 2024 | -448.70% |
| Mar 31, 2024 | -183.90% |
| Dec 31, 2023 | -107.20% |
| Sep 30, 2023 | -81.10% |
| Jun 30, 2023 | -59.84% |
| Mar 31, 2023 | -44.79% |
| Dec 31, 2022 | -50.64% |
| Sep 30, 2022 | -46.57% |
| Jun 30, 2022 | -40.29% |
| Mar 31, 2022 | -44.33% |
| Dec 31, 2021 | -39.21% |
| Sep 30, 2021 | -34.27% |
| Jun 30, 2021 | -74.98% |
| Dec 31, 2020 | -924.38% |
| Sep 30, 2020 | -741.60% |
| Jun 30, 2020 | -1,035.69% |
API Access
Protagenic Therapeutics, Inc.\new Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();